Focus: Infinant Health is a Davis, CA-based biotechnology company specializing in probiotic bacteria for gastroenterology applications. The company operates at a modest scale with limited public disclosure of employee count and funding.
Profile data last refreshed Yesterday · AI intelligence enriched 2w ago
No open roles listed right now. Follow Infinant Health to get notified when they start hiring — the background below is worth knowing for when they do.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Help build intelligence for Infinant Health
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from Infinant Health's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Only branded NDA product with patent protection until 2038; norepinephrine is a critical care commodity with thin margins and high generic competition.
Post-LOE ANDA generic with no exclusivity; standard-of-care electrolyte with minimal differentiation.
Multiple duplicate ANDA filings suggest portfolio depth in commoditized critical-care generics; minimal revenue upside.
2 discontinued, 7 duplicate formulations not shown
No open positions listed yet. Check their careers page directly.
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/mo